{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:43:09Z","timestamp":1793652189300,"version":"4.5.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017539","name":"Theodor Bilharz Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017539","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anemia of inflammation (AI) represents the second most prevalent anemia globally particularly in conditions of prolonged immune activation including hemodialysis (HD). While the role of pro-inflammatory cytokines in disrupting iron homeostasis and erythropoiesis is well-established, the regulatory mechanisms involving microRNAs (miRNAs) remain incompletely elucidated. The current study investigates the intricate relationships between cytokines and miRNAs in the pathogenesis of AI among HD patients. The study comprised 30 HD patients with AI and 30 healthy controls. Expression profile of inflammatory cytokines (IL-6, TNF-\u03b1) and inflammation-associated miRNAs (miR-34, miR-130, miR-16b) were analyzed using quantitative real-time PCR. Serum C-reactive protein (CRP) and iron metabolism markers (serum iron, ferritin, transferrin saturation and total iron binding capacity) were analyzed. Correlation analyses and pathway enrichment studies were performed to identify cytokine-miRNA regulatory networks. HD with AI exhibited significant overexpression of IL-6, TNF-\u03b1 and miR-34 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), while miR-130 and miR-16b were significantly downregulated (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) compared to control group. MiR-34 was positively correlated with IL-6 (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.96,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001) and TNF-\u03b1 (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.98,\n                    <jats:italic>p\u2009=<\/jats:italic>\n                    \u20090.001), while it showed significant inverse correlation with miR-130 and miR-16b (\n                    <jats:italic>p\u2009=<\/jats:italic>\n                    \u20090.001 for both). Furthermore, strong positive associations were observed between lower levels of transferrin saturation and decreased expression of IL-6, TNF-\u03b1 and miR-16b (\n                    <jats:italic>p\u2009=<\/jats:italic>\n                    \u20090.01, 0.009, 0.001 respectively). The markedly increased ferritin levels (&gt;\u2009600\u00a0mg\/mL) showed direct positive relationship with elevated expression of IL-6 and TNF-\u03b1 in HD with AI. The present findings are exploratory and hypothesis-generating, suggesting possible relationship between miRNA dysregulation and the development of AI in HD patients, and provide the rationale for external validation in larger, independent HD cohorts. The interaction between miRNA expression and cytokine signaling may provide novel insights into the mechanism that could perpetuate AI in HD unravelling potential therapeutic targets that could mitigate the inflammatory response ultimately improving patient outcomes.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-49829-w","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:24:58Z","timestamp":1779089098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The interplay between cytokine genes and microRNAs in anemia of inflammation among hemodialysis patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohamed","family":"Shemis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevine","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Mamdouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"El-Shishtawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Abdeltawab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola B.","family":"Abo El Nil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany M.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-3715","authenticated-orcid":false,"given":"Sherihan G.","family":"AbdelHamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"49829_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-3-031-92033-2_13","volume":"1480","author":"L Lanser","year":"2025","unstructured":"Lanser, L. & Weiss, G. Anemia of inflammation. Adv. Exp. Med. Biol. 1480, 179\u2013195 (2025).","journal-title":"Adv. Exp. Med. Biol."},{"key":"49829_CR2","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1182\/blood.2021013472","volume":"140","author":"O Marques","year":"2022","unstructured":"Marques, O., Weiss, G. & Muckenthaler, M. The role of iron in chronic inflammatory diseases: From mechanisms to treatment options in anemia of inflammation. Blood 140, 2011\u20132023 (2022).","journal-title":"Blood"},{"key":"49829_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra1804281","volume":"381","author":"T Ganz","year":"2019","unstructured":"Ganz, T. Anemia of inflammation. N. Engl. J. Med. 381, 1148\u20131157 (2019).","journal-title":"N. Engl. J. Med."},{"key":"49829_CR4","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/biomedicines12061191","volume":"12","author":"K Badura","year":"2024","unstructured":"Badura, K. et al. Anemia of chronic kidney disease\u2014A narrative review of its pathophysiology, diagnosis, and management. Biomedicines 12, 1191 (2024).","journal-title":"Biomedicines"},{"key":"49829_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.108","volume":"8","author":"A Iolascon","year":"2024","unstructured":"Iolascon, A. et al. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. HemaSphere 8, e108. https:\/\/doi.org\/10.1002\/hem3.108 (2024).","journal-title":"HemaSphere"},{"issue":"9","key":"49829_CR6","doi-asserted-by":"publisher","first-page":"e2433126","DOI":"10.1001\/jamanetworkopen.2024.33126","volume":"7","author":"Y Tawfik","year":"2024","unstructured":"Tawfik, Y. et al. Absolute and functional iron deficiency in the US, 2017\u20132020. JAMA Netw. Open. 7(9), e2433126 (2024).","journal-title":"JAMA Netw. Open."},{"key":"49829_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","volume":"18","author":"A Bello","year":"2022","unstructured":"Bello, A. et al. Epidemiology of haemodialysis outcomes. Nat. Rev. Nephrol. 18, 378\u2013395 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"49829_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"49829_CR9","unstructured":"Egyptian Cabinet. (2024). https:\/\/www.cabinet.gov.eg\/News\/Details\/75563 accessed on 15th may 2024."},{"issue":"1","key":"49829_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000098522","volume":"30","author":"J Malyszko","year":"2007","unstructured":"Malyszko, J. & Mysliwiec, M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press. Res. 30(1), 15\u201330 (2007).","journal-title":"Kidney Blood Press. Res."},{"issue":"3","key":"49829_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000135655","volume":"31","author":"H El-Mesallamy","year":"2008","unstructured":"El-Mesallamy, H., Abdel Hamid, S. & Gad, M. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: Improvements by L-arginine intake. Kidney Blood Press. Res. 31(3), 189\u2013195 (2008).","journal-title":"Kidney Blood Press. Res."},{"key":"49829_CR12","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s42765-023-00277-5","volume":"5","author":"H Ji","year":"2023","unstructured":"Ji, H. et al. Advances in enhancing hemocompatibility of hemodialysis hollow-fiber membranes. Adv. Fiber Mater. 5, 1198\u20131240 (2023).","journal-title":"Adv. Fiber Mater."},{"issue":"Suppl_1","key":"49829_CR13","doi-asserted-by":"publisher","first-page":"i18","DOI":"10.1093\/ndtplus\/sfn176","volume":"2","author":"A De Francisco","year":"2009","unstructured":"De Francisco, A., Stenvinkel, P. & Vaulont, S. Inflammation and its impact on anemia in chronic kidney disease: From hemoglobin variability to hyporesponsiveness. NDT Plus 2(Suppl_1), i18\u2013i26 (2009).","journal-title":"NDT Plus"},{"issue":"4","key":"49829_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1590\/2175-8239-jbn-2018-0092","volume":"41","author":"J Plastina","year":"2019","unstructured":"Plastina, J. et al. Functional iron deficiency in patients on hemodialysis: Prevalence, nutritional assessment, and biomarkers of oxidative stress and inflammation. Braz. J. Nephrol. 41(4), 472\u201380 (2019).","journal-title":"Braz. J. Nephrol."},{"issue":"6","key":"49829_CR15","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1046\/j.1523-1755.2002.00076.x","volume":"61","author":"G Kaysen","year":"2002","unstructured":"Kaysen, G. et al. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 61(6), 2240\u20139 (2002).","journal-title":"Kidney Int."},{"issue":"4","key":"49829_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.hoc.2014.04.005","volume":"28","author":"E Nemeth","year":"2014","unstructured":"Nemeth, E. & Ganz, T. Anemia of inflammation. Hematol. Oncol. Clin. N. Am. 28 (4), 671\u2013681 (2014). vi.","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"2","key":"49829_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3324\/haematol.2019.232124","volume":"105","author":"C Camaschella","year":"2020","unstructured":"Camaschella, C., Nai, A. & Silvestri, L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica 105 (2), 260\u2013272 (2020).","journal-title":"Haematologica"},{"issue":"6","key":"49829_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253475","volume":"16","author":"C Edouard","year":"2021","unstructured":"Edouard, C. & Kostas, P. Iron overload inhibits BMP\/SMAD and IL-6\/STAT3 signaling to hepcidin in cultured hepatocytes. PLoS One 16(6), e0253475. https:\/\/doi.org\/10.1371\/journal.pone.0253475 (2021).","journal-title":"PLoS One"},{"key":"49829_CR19","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/nu11102424","volume":"11","author":"S Begum","year":"2019","unstructured":"Begum, S. & Latunde-Dada, G. Anemia of inflammation with an emphasis on chronic kidney disease. Nutrients 11, 2424 (2019).","journal-title":"Nutrients"},{"key":"49829_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.omtn.2020.04.002","volume":"20","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty, C., Sharma, A. R., Sharma, G. & Lee, S. S. The interplay among miRNAs, major cytokines, and cancer-related inflammation. Mol. Ther. Nucleic Acids 20, 606\u2013620. https:\/\/doi.org\/10.1016\/j.omtn.2020.04.002 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"49829_CR21","first-page":"1","volume":"8","author":"W Jessye","year":"2021","unstructured":"Jessye, W., C, E. & Roth Terri, L. Rhinoceros serum microRNAs: Identification, characterization, and evaluation of potential iron overload biomarkers. Front. Vet. Sci. 8, 1\u20139 (2021).","journal-title":"Front. Vet. Sci."},{"key":"49829_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrd.2018.45","volume":"17","author":"C Garbers","year":"2018","unstructured":"Garbers, C. et al. Interleukin-6: designing specific therapeutics for a complex cytokine. Nat. Rev. Drug Discov. 17, 395\u2013412 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"23","key":"49829_CR23","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.21037\/atm-21-4357","volume":"9","author":"B Abdel Azeem","year":"2012","unstructured":"Abdel Azeem, B. et al. The efficacy of Roxadustat for the treatment of anemia in dialysis dependent chronic kidney disease patients: an updated systematic review and meta-analysis of randomized clinical trials. Ann. Transl. Med. 9(23), 1714 (2012).","journal-title":"Ann. Transl. Med."},{"key":"49829_CR24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA 310, 2191\u20132194 (2013).","journal-title":"JAMA"},{"issue":"4S","key":"49829_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 100(4S), S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021 (2021).","journal-title":"Kidney Int."},{"issue":"D1","key":"49829_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"S Vasaikar","year":"2017","unstructured":"Vasaikar, S., Straub, P., Wang, J. & Zhang, B. LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. gkx1090. https:\/\/doi.org\/10.1093\/nar\/gkx1090 (2017).","journal-title":"Nucleic Acids Res."},{"key":"49829_CR27","unstructured":"Akin, Y., Hacer, I., Ebru, A. & Sevda, M. Real-time PCR for gene expression analysis. In: polymerase chain reaction. In Tech Journals (eds Hernandez, P. & Gomez, A.)\u00a0Chapter 12, 229\u2009\u2013\u2009254 (2012)."},{"issue":"7","key":"49829_CR28","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1091\/mbc.e07-01-0060","volume":"18","author":"I De Domenico","year":"2007","unstructured":"De Domenico, I. et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18(7), 2569\u201378 (2007).","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"49829_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1542-4758.2009.00352.x","volume":"13","author":"L Chawla","year":"2009","unstructured":"Chawla, L. & Krishnan, M. Causes and consequences of inflammation on anemia management in hemodialysis patients. Hemodial. Int. 13(2), 222\u201334 (2009).","journal-title":"Hemodial. Int."},{"issue":"1","key":"49829_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/16078454.2020.1757332","volume":"25","author":"S Lu","year":"2020","unstructured":"Lu, S., Yadav, A. & Qiao, X. Identification of potential miRNA-mRNA interaction network in bone marrow T cells of acquired aplastic anemia. Hematology 25(1), 168\u2013175. https:\/\/doi.org\/10.1080\/16078454.2020.1757332 (2020).","journal-title":"Hematology"},{"key":"49829_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415479","volume":"23","author":"K Das","year":"2022","unstructured":"Das, K. & Rao, L. The Role of microRNAs in inflammation. Int. J. Mol. Sci. 23, 15479. https:\/\/doi.org\/10.3390\/ijms232415479 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"49829_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s43162-022-00148-2","volume":"34","author":"A Fouad","year":"2022","unstructured":"Fouad, A. et al. Serum miR\u201134a as a potential biomarker for diagnosis of inflammatory bowel diseases in Egyptian patients. Egypt. J. Intern. Med. 34, 64. https:\/\/doi.org\/10.1186\/s43162-022-00148-2 (2022).","journal-title":"Egypt. J. Intern. Med."},{"issue":"7","key":"49829_CR33","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.03.161","volume":"8","author":"N Zhao","year":"2020","unstructured":"Zhao, N. et al. MicroRNA-34a deficiency leads to impaired wound closure by augmented inflammation in mice. Ann. Transl. Med. 8(7), 447. https:\/\/doi.org\/10.21037\/atm.2020.03.161 (2020).","journal-title":"Ann. Transl. Med."},{"issue":"34","key":"49829_CR34","doi-asserted-by":"publisher","first-page":"23796","DOI":"10.1074\/jbc.M114.577387","volume":"289","author":"K Zumbrennen-Bullough","year":"2014","unstructured":"Zumbrennen-Bullough, K. et al. MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription. J. Biol. Chem. 289(34), 23796\u201323808. https:\/\/doi.org\/10.1074\/jbc.M114.577387 (2014).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"49829_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948075","volume":"7","author":"SD Gurien","year":"2020","unstructured":"Gurien, S. D. et al. Extracellular microRNA 130b-3p inhibits eCIRP-induced inflammation. EMBO Rep. 7(1), e48075. https:\/\/doi.org\/10.15252\/embr.201948075 (2020).","journal-title":"EMBO Rep."},{"key":"49829_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5114\/aoms.2018.74950","volume":"2","author":"K Du","year":"2021","unstructured":"Du, K., He, X. & Jiaqin Deng, J. MicroRNA-16 inhibits the lipopolysaccharide-induced inflammatory response in nucleus pulposus cells of the intervertebral disc by targeting TAB3. Arch. Med. Sci. 2, 500\u2013513 (2021).","journal-title":"Arch. Med. Sci."},{"key":"49829_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073745","volume":"25","author":"T Matsuoka","year":"2024","unstructured":"Matsuoka, T., Abe, M. & Kobayashi, H. Iron metabolism and inflammatory mediators in patients with renal dysfunction. Int. J. Mol. Sci. 25, 3745. https:\/\/doi.org\/10.3390\/ijms25073745 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"49829_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179218","volume":"12","author":"M Dziedzic","year":"2017","unstructured":"Dziedzic, M. et al. Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients. PLoS One 12(6), e0179218. https:\/\/doi.org\/10.1371\/journal.pone.0179218 (2017).","journal-title":"PLoS One"},{"key":"49829_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000329573","volume":"32","author":"S Bowry","year":"2011","unstructured":"Bowry, S. & Gatti, E. Impact of hemodialysis therapy on anemia of chronic kidney disease: The potential mechanisms. Blood Purif. 32, 210\u2013219. https:\/\/doi.org\/10.1159\/000329573 (2011).","journal-title":"Blood Purif."},{"issue":"18","key":"49829_CR40","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1182\/blood-2011-03-345066","volume":"118","author":"G Theurl","year":"2011","unstructured":"Theurl, G. et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 118(18), 4977\u20134984. https:\/\/doi.org\/10.1182\/blood-2011-03-345066 (2011).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49829-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49829-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49829-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:40:06Z","timestamp":1779090006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49829-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49829"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49829-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent to publish has been received from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Theodor Bilharz Research Institute\u00a0(PT611\/28),\u00a0under the Federal Wide Assurance No. FWA00010609.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15334"}}